'Halftime Report' Traders Share Their Thoughts On Crispr Therapeutics And Bed Bath & Beyond

Loading...
Loading...

Amy Raskin said on CNBC's "Fast Money Halftime Report" that she would hold Crispr Therapeutics AG CRSP. She doesn't own the stock, but she owns Intellia Therapeutics Inc NTLA in the space.

Pete Najarian sees Bed Bath & Beyond Inc. BBBY as a trading vehicle because of volatile trading. A lot of that has to do with the short interest of the company.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: MediaAmy RaskinCNBCFast Money Halftime ReportPete Najarian
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...